trial

Sensitivity, Threshold, Tolerance and Pain Recognition in Schizophrenia Patients and Their Relatives.

NCTId NCT05345548
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 200 (estimated)
Sponsored by HaEmek Medical Center, Israel
Primary completion 2023-12-29
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
200 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2019-08-29
Primary completion
2023-12-29
Eligibility
FEMALE · 18 Years

Interventions & indications

Drugs
Cold Pressor test

Sponsors

HaEmek Medical Center, IsraelLead Sponsor

Investigators

1
Einat Mader, MDPrincipal Investigator

Sites

1 total
Afula, Israel

Facts & assertions

4 sourced
Enrollment
200
Phase
NA
Primary Completion Date
2023-12-29
Status
UNKNOWN
relationships
The graph out of here
drug
Cold Pressor test
drug
lead_sponsor
HaEmek Medical Center, Israel
company
indication
Schizophrenia
indication
Schizophrenia
indication
Pain Recognition
indication
investigator
Einat Mader, MD
person